| | Title | Authors / Editors | Date |
|
unige:45959 |
Biological agents in monotherapy for the treatment of rheumatoid arthritis |
Gabay, Cem; Hasler, P; Kyburz, D; So, A; ... Walker, U |
2014 |
|
unige:110908 |
Body mass does not impact the clinical response to intravenous abatacept in patients with rheumatoid arthritis. Analysis from the "pan-European registry collaboration for abatacept (PANABA) |
Iannone, Florenzo; Courvoisier, Delphine S; Gottenberg, Jacques Eric; Hernandez, Maria Victoria; ... Finckh, Axel |
2017 |
|
unige:32505 |
Differential drug retention between anti-TNF agents and alternative biological agents after inadequate response to an anti-TNF agent in rheumatoid arthritis patients |
Martin-du-pan, Sophie Marie Catherine; Scherer, Almut; Gabay, Cem; Finckh, Axel |
2012 |
|
unige:25087 |
Do new biologics meet the unmet medical need in rheumatoid arthritis? Safety and efficacy of abatacept following B-cell depletion |
Walker, Ulrich A; Courvoisier, Delphine; Dudler, Jean; Aeberli, Daniel; ... Finckh, Axel |
2011 |
|
unige:110910 |
Does addition of glucocorticoids to the initial therapy influence the later course of the disease in patients with early RA? Results from the Swiss prospective observational registry (SCQM) |
Mueller, Ruediger B; Reshiti, Nazim; Kaegi, Toni; Finckh, Axel; ... von Kempis, Johannes |
2017 |
|
unige:32495 |
Effectiveness of disease-modifying antirheumatic drug co-therapy with methotrexate and leflunomide in rituximab-treated rheumatoid arthritis patients: results of a 1-year follow-up study from the CERERRA collaboration |
Chatzidionysiou, Katerina; Lie, Elisabeth; Nasonov, Evgeny; Lukina, Galina; ... Gabay, Cem |
2012 |
|
unige:110657 |
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update |
EULAR |
2017 |
|
unige:43955 |
Henoch Schönlein purpura following etanercept treatment of rheumatoid arthritis |
Duffy, T N; Genta, Marcia; Moll, Solange; Martin, Pierre-Yves; Gabay, Cem |
2006 |
|
unige:25201 |
Indirect comparisons of the efficacy of biological antirheumatic agents in rheumatoid arthritis in patients with an inadequate response to conventional disease-modifying antirheumatic drugs or to an anti-tumour necrosis factor agent: a meta-analysis |
Salliot, Carine; Finckh, Axel; Katchamart, Wanruchada; Lu, Yan; ... Keystone, Edward |
2011 |
|
unige:2048 |
Neurological and pulmonary adverse effects of subcutaneous methotrexate therapy |
Sommer, W H.; Ganiere, Vincent; Gachoud, D.; Keta, A.; ... Aujesky, D. |
2008 |
|
unige:29849 |
Proteasome inhibition: a new anti-inflammatory strategy |
Elliott, Peter J.; Zollner, Thomas Matthias; Boehncke, Wolf-Henning |
2003 |
|
unige:110911 |
Risk of invasive melanoma in patients with rheumatoid arthritis treated with biologics: results from a collaborative project of 11 European biologic registers |
Mercer, Louise K; Askling, Johan; Raaschou, Pauline; Dixon, William G; ... Listing, Joachim |
2017 |
|
unige:86816 |
Rituximab done: what's next in rheumatoid arthritis? A European observational longitudinal study assessing the effectiveness of biologics after rituximab treatment in rheumatoid arthritis |
Walker, Ulrich A; Jaeger, Veronika K; Chatzidionysiou, Katerina; Hetland, Merete L; ... Gabay, Cem |
2016 |
Arthritis, rheumatoid/drug therapy
add all
remove all
